Overview

Systemic Synuclein Sampling Study (S4)

Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure alpha-synuclein in peripheral body tissues and fluids in Parkinson's disease (PD). This may help in developing better treatments for PD patients in the future.
Details
Lead Sponsor:
Michael J. Fox Foundation for Parkinson's Research
Collaborators:
Banner Health
Indiana University
Paracelsus Elena Klinik
University of Iowa